| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC | Principal Accounting Officer | Common Stock | 242,996 | $96,833 | $0.3985 | 22 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | 22 Jan 2026 | 1 | -$3,077 | 4 | Principal Accounting Officer | 26 Jan 2026, 16:14 |
| SGMO | SANGAMO THERAPEUTICS, INC | 24 Nov 2025 | 1 | -$241 | 4 | Principal Accounting Officer | 26 Nov 2025, 16:10 |
| SGMO | SANGAMO THERAPEUTICS, INC | 22 Oct 2025 | 1 | -$4,427 | 4 | Principal Accounting Officer | 24 Oct 2025, 17:00 |
| SGMO | SANGAMO THERAPEUTICS, INC | 01 Oct 2025 | 0 | $0 | 3 | Principal Accounting Officer | 09 Oct 2025, 18:49 |